The interferon-natural killer cell system of patients with ovarian tumors
Sorokin, A.M.; Moiseeva, N.B.; Cheredeev, A.N.; Frolova, I.S.
Akusherstvo i Ginekologiia 5: 23-27
1988
ISSN/ISBN: 0300-9092 PMID: 2459982 Document Number: 317463
Document emailed within 1 workday
Related Documents
Lotzová, E.; Savary, C.A.; Quesada, J.R.; Gutterman, J.U.; Hersh, E.M. 1983: Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon Journal of the National Cancer Institute 71(5): 903-910Gustafsson, A.; Sundström, S.; Lundgren, E. 1986: The augmentation of human natural killer cell activity by interferon-gamma is not associated with the induction of the interferon-alpha-inducible proteins Journal of Immunology 137(1): 167-171
Rook, A.H.; Hooks, J.J.; Quinnan, G.V.; Lane, H.C.; Manischewitz, J.F.; Macher, A.M.; Masur, H.; Fauci, A.S.; Djeu, J.Y. 1985: Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism Journal of Immunology 134(3): 1503-1507
Miller, V.E.; Pohajdak, B.; Greenberg, A.H. 1983: Murine natural antitumor antibodies. III. Interferon treatment of a natural killer-resistant lymphoma: augmentation of natural antibody reactivity and susceptibility to in vivo natural resistance Journal of the National Cancer Institute 71(2): 377-384
Gibson, J.; Gallagher, K.; Cameron, K.; Basten, A.; Gatenby, P.; Joshua, D.; Kronenberg, H. 1988: Peripheral blood lymphocyte subsets and natural killer cell number and function during alpha-interferon treatment for hairy cell leukemia Australian and New Zealand Journal of Medicine 18(7): 897-899
Cheknev, S.B.; Ashmanova, I.G.; Pritsker, A.D.; Latysheva, O.L. 1994: Circulating serum interferon and its effect on human natural killer cell activity Biulleten' Eksperimental'noi Biologii i Meditsiny 118(12): 619-622
Wolf, S.F.; Temple, P.A.; Kobayashi, M.; Young, D.; Dicig, M.; Lowe, L.; Dzialo, R.; Fitz, L.; Ferenz, C.; Hewick, R.M. 1991: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells Journal of Immunology 146(9): 3074-3081
Goldfarb, R.H.; Herberman, R.B. 1981: Natural killer cell reactivity: regulatory interactions and among phorbol ester, interferon, cholera toxin, and retinoic acid Journal of Immunology 126(6): 2129-2135
Ojo-Amaize, E.A.; Salimonu, L.S.; Williams, A.I.; Akinwolere, O.A.; Shabo, R.; Alm, G.V.; Wigzell, H. 1981: Positive correlation between degree of parasitemia, interferon titers, and natural killer cell activity in Plasmodium falciparum-infected children Journal of Immunology 127(6): 2296-2300
Yang, F.C.; Yabuhara, A.; Koike, K. 1994: Absence of responsiveness to interferon-gamma but not to interleukin 2 and depressed recycling as natural killer cell abnormalities in childhood lymphohistiocytic syndrome International Journal of Hematology 59(4): 273-280
Lee, S.H.; Kelley, S.; Chiu, H.; Stebbing, N. 1982: Stimulation of natural killer cell activity and inhibition of proliferation of various leukemic cells by purified human leukocyte interferon subtypes Cancer Research 42(4): 1312-1316
Hayakawa, K.; Salmeron, M.A.; Kornbluth, J.; Bucana, C.; Itoh, K. 1991: The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone Journal of Immunology 146(7): 2453-2460
Gorelik, E.; Herberman, R.B. 1981: Susceptibility of various strains of mice to urethan-induced lung tumors and depressed natural killer cell activity Journal of the National Cancer Institute 67(6): 1317-1322
Müller, C.; Zielinski, C.C. 1987: Spontaneous and interferon-induced activity of natural killer cells in patients with liver cirrhosis and chronic active hepatitis Acta Medica Austriaca 14(5): 115-118
Feickert, H.J.; Pietsch, T.; Hadam, M.R.; Mildenberger, H.; Riehm, H. 1989: Monoclonal antibody T-199 directed against human medulloblastoma: characterization of a new antigenic system expressed on neuroectodermal tumors and natural killer cells Cancer Research 49(15): 4338-4343
Actis, G.C.; Maran, E.; Bonino, F.; Saracco, G.; Rosina, F.; Brunetto, M.R.; Baldi, M.; Rizzetto, M.; Verme, G.; Rocca, B. 1987: Patterns of natural killer cell function activation in response to interferon in chronic HBsAG positive hepatitis: relationship with the state of viral infection and with the early clinical response Journal of Biological Regulators and Homeostatic Agents 1(1): 45-50
Shirakawa, F.; Tanaka, Y.; Eto, S.; Suzuki, H.; Yodoi, J.; Yamashita, U. 1986: Effect of interleukin 1 on the expression of interleukin 2 receptor (Tac antigen) on human natural killer cells and natural killer-like cell line (YT cells) Journal of Immunology 137(2): 551-556
Pál, E.; Varjú, G.; Vécsei, L.; Szekeres, J.; Pálffy, G. 1997: Natural killer cell activity in multiple sclerosis patients Orvosi Hetilap 138(50): 3167-3170
Seth, P. 1983: Natural killer cell activity in patients with cervical cancer Indian Journal of Medical Research 78: 689-693
Sirianni, M.C.; Businco, L.; Fiore, L.; Seminara, R.; Aiuti, F. 1983: T-cell subsets and natural killer cells in DiGeorge and SCID patients Birth Defects Original Article Series 19(3): 107-108